Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > events calendar

PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

EVENTS FOR 2020

next year

January	February	March	April
May	June	July	August
September	October	November	December
Show all events

EVENTS FOR ALL MAGAZINES

EPC	EBR	ICT	PMPS
Show all

July 2020

Evolution Summit

20-22 July 2020
The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development. More>>

	events.marcusevans-events.com/evolutionmay-2020/
	The Ritz Carlton, Fort Lauderdale, FL

INTERPHEX 2020

15-17 July 2020
Javits Center NYC

More>>

	(203) 840-5455
	KScott@reedexpo.com
	bit.ly/2ET106L
	Javits Center, New York, USA

Formulation and Drug Delivery Series UK

8-9 July 2020
Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development. More>>

	01865 248455
	e.hawkings@oxfordglobal.co.uk
	https://bit.ly/2SXCR4w
	Search Results Godstow Court, Minns Business Park, Botley, Oxford OX2 0JB

Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC

More info >>

All events >>

	White Papers
All white papers >>

News and Press Releases

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >>

All releases >>